SEC Form 4 · accession 0001073397-18-000002

ICU MEDICAL INC/DE · ICUI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

George A Lopez

Director · 10% Owner

Period of report

Mar 19, 2018

Accepted (ET)

Mar 21, 2018 · 3:23 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000883984

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Mar 19, 2018	S	1,142	$247.2193	D	526,574	D
Common Stock^F3	Mar 19, 2018	S	4,967	$248.3592	D	521,607	D
Common Stock^F4	Mar 19, 2018	S	1,804	$249.4896	D	519,803	D
Common Stock^F5	Mar 19, 2018	S	2,000	$250.5125	D	517,803	D
Common Stock^F6	Mar 19, 2018	S	2,629	$251.6562	D	515,174	D
Common Stock^F7	Mar 19, 2018	S	901	$252.5862	D	514,273	D
Common Stock^F8	Mar 20, 2018	S	600	$249.8833	D	513,673	D
Common Stock^F9	Mar 20, 2018	S	4,758	$250.9031	D	508,915	D
Common Stock^F10	Mar 20, 2018	S	2,702	$251.8872	D	506,213	D
Common Stock^F11	Mar 20, 2018	S	3,857	$252.9106	D	502,356	D
Common Stock	Mar 21, 2018	S	100	$248.70	D	502,256	D
Common Stock	Mar 21, 2018	S	100	$249.80	D	502,156	D
Common Stock^F12	Mar 21, 2018	S	1,310	$251.763	D	500,846	D
Common Stock^F13	Mar 21, 2018	S	1,514	$253.0928	D	499,332	D
Common Stock^F14	Mar 21, 2018	S	2,413	$254.3241	D	496,919	D
Common Stock^F15	Mar 21, 2018	S	1,803	$255.3331	D	495,116	D
Common Stock	Mar 21, 2018	S	400	$256.00	D	494,716	D
Common Stock	holding	—	—		—	986,843	I	by Partnership

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.
F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.40 to $252.40 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F11The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.45 to $253.25 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F12The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.35 to $252.10 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F13The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.70 to $253.60 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F14The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.75 to $254.75 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F15The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.90 to $255.90 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.75 to $247.70, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.80 to $248.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.95 to $249.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $251.00 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.10 to $252.10 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.15 to $253.05 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.30 to $250.20 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.35 to $251.35 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.